查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美腸內營養市場預測至 2030 年 - 區域分析 - 按產品類型、應用、年齡層和配銷通路
市場調查報告書
商品編碼
1494338

北美腸內營養市場預測至 2030 年 - 區域分析 - 按產品類型、應用、年齡層和配銷通路

North America Enteral Nutrition Market Forecast to 2030 - Regional Analysis - by Product Type, Application, Age Group, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 114 Pages | 訂單完成後即時交付

價格

2022年北美腸內營養市場價值為32.0658億美元，預計到2030年將達到51.8748億美元；預計2022年至2030年複合年成長率為6.2%。

胃腸道疾病盛行率的增加推動了北美腸內營養市場

胃腸道疾病包括克隆氏症、腸阻塞、潰瘍性結腸炎、短腸症候群、顯微鏡下結腸炎和某些癌症類型。根據 2019 年全球疾病負擔研究，2019 年全球記錄了約 490 萬例發炎性腸道疾病 (IBD) 病例；美國（762,890 例）的病例數最多，盛行率分別為每 10 萬人中 66.9 例和 245.3 例。克隆氏症是一種複雜的慢性疾病，主要影響消化系統。此外，每年每 100 萬人中約有 3 人患有短腸症候群 (SBS)。根據 2020 年發表的題為「了解短腸症候群：現況與未來展望」的文章，SBS 的盛行率在過去 40 年中增加了兩倍多。在美國，SBS 的盛行率約為每 1,000 萬人中有 300 例。

患有胃腸道疾病的患者營養惡化的風險較高，因為他們被要求在接受診斷測試之前禁食。他們也可能因治療性飲食限制而面臨營養惡化，以及厭食症或營養需求改變引起的食慾不振，這可能是疾病本身造成的。因此，由於這些患者無法攝取食物，建議進行醫學營養治療。優選腸內途徑來提供他們必需的營養。腸內餵食是指透過口腔或經由消化道（口腔到胃/小腸，然後肛門）的管道直接攝取食物營養物質。這種類型的營養優選為患有慢性疾病的患者提供治療支持，例如神經系統疾病、胃腸道疾病和遺傳性代謝疾病。因此，胃腸道疾病盛行率的激增推動了腸內營養市場的成長。

北美腸內營養市場概況

北美腸內營養市場分為美國、加拿大和墨西哥。由於慢性病盛行率不斷上升、市場參與者不斷發展的策略發展以及對腸內營養的日益偏好，北美佔據了重要的市場佔有率，這些都促進了該地區的市場進步。此外，人們對醫療營養（例如管飼）在治療慢性健康狀況方面的益處的認知不斷增加，預計將在預測期內推動北美腸內營養市場的成長。

癌症和心臟病等慢性疾病是美國殘疾和死亡的主要原因。根據國家慢性病預防和健康促進中心的數據，全國十分之六的人至少患有一種慢性病。此外，美國醫院協會估計約有 1.33 億人患有至少一種慢性病，預計到 2030 年這一數字將達到 1.7 億人。

北美腸內營養市場收入及 2030 年預測（百萬美元）

北美腸內營養市場細分

北美腸內營養市場根據產品類型、應用、年齡層、配銷通路和國家進行細分。

根據產品類型，北美腸內營養市場分為一般型和特定疾病型。到 2022 年，普通細分市場將佔據更大的北美腸內營養市場。

在應用方面，北美腸內營養市場細分為胃腸道疾病、代謝/先天性代謝缺陷、食物過敏、腎臟疾病、肝臟疾病、腫瘤學、神經病學等。 2022 年，胃腸道疾病領域佔據北美腸內營養市場最大佔有率。

根據年齡層，北美腸內營養市場分為成人和兒童。到 2022 年，成人細分市場將佔據更大的北美腸內營養市場。

依配銷通路，北美腸內營養市場分為醫院藥局、零售店、電子商務等。 2022 年，醫院藥局部門佔據北美腸內營養市場最大佔有率。

依國家分類，北美腸內營養市場分為美國、加拿大和墨西哥。 2022年，美國主導北美腸內營養市場。

Abbott Laboratories、雀巢 SA、達能 SA、Fresenius SE & Co KGaA、B Braun SE、Dr Schar AG、Reckitt Benckiser Group Plc、 Nutritional Medicinals LLC、Kate Farms Inc、Royal FrieslandCampina NV、Arla Foods amba、Perrigo Co Plc 和 Font Co Plc -Operative Group Ltd 是北美腸內營養市場上的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美腸內營養市場 - 主要產業動態

  • 主要市場促進因素：
    • 胃腸道疾病盛行率增加
    • 營養不良和早產病例不斷增加
  • 市場限制
    • 與腸內餵食系統相關的併發症
  • 市場機會
    • 主要市場參與者的策略性舉措
  • 未來的趨勢
    • 特定配方和植物性營養產品
  • 影響分析

第 5 章：腸內營養市場 - 北美市場分析

  • 北美腸內營養市場收入，2022 - 2030

第 6 章：北美腸內營養市場 - 2030 年收入與預測 - 按產品類型

  • 概述
  • 北美腸內營養市場收入佔有率，按產品類型 2022 年和 2030 年 (%)
  • 一般的
  • 特定疾病

第 7 章：北美腸內營養市場 - 2030 年收入與預測 - 按應用

  • 概述
  • 2022 年及 2030 年北美腸內營養市場收入佔有率，依應用分類 (%)
  • 胃腸道疾病
  • 代謝/先天性代謝缺陷
  • 過敏
  • 腎臟疾病
  • 肝病
  • 腫瘤學
  • 神經病學
  • 其他

第 8 章：北美腸內營養市場 - 收入和 2030 年預測 - 按年齡層

  • 概述
  • 北美腸內營養市場收入佔有率，按年齡層 2022 年和 2030 年 (%)
  • 成人
  • 兒科

第 9 章：北美腸內營養市場 - 2030 年收入和預測 - 按配銷通路

  • 概述
  • 2022 年及 2030 年北美腸內營養市場收入佔有率，依配銷通路分類 (%)
  • 醫院藥房
  • 零售店
  • 電子商務
  • 其他

第 10 章：北美腸內營養市場 - 國家分析

  • 美國
  • 加拿大
  • 墨西哥

第 11 章：腸內營養市場-產業格局

  • 概述
  • 腸內營養市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 12 章：公司簡介

  • Abbott Laboratories
  • Nestle SA
  • Danone SA
  • Fresenius SE & Co KGaA
  • B Braun SE
  • Dr Schar AG
  • Reckitt Benckiser Group Plc
  • Nutritional Medicinals LLC
  • Kate Farms Inc
  • Royal FrieslandCampina NV
  • Arla Foods amba
  • Perrigo Co Plc
  • Fonterra Co-Operative Group Ltd

第 13 章：附錄

Product Code: BMIRE00029862

The North America enteral nutrition market was valued at US$ 3,206.58 million in 2022 and is expected to reach US$ 5,187.48 million by 2030; it is estimated to grow at a CAGR of 6.2% from 2022 to 2030.

Increasing Prevalence of Gastrointestinal Diseases Fuel North America Enteral Nutrition Market

Gastrointestinal diseases include Crohn's disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and certain cancer types. As per the Global Burden of Disease Study 2019, ~4.9 million cases of inflammatory bowel disease (IBD) were recorded worldwide in 2019; the US (762,890) had the highest number of cases, with prevalence of 66.9 and 245.3 cases per 100,000 people, respectively. Crohn's disease is a complex, chronic disorder primarily affecting the digestive system. Moreover, short bowel syndrome (SBS) occurs in ~3 per 1 million people yearly. As per the article titled "Understanding Short Bowel Syndrome: Current Status and Future Perspectives," published in 2020, the prevalence of SBS has increased by more than twofold in the last 40 years. The prevalence of SBS was ~300 cases per 10 million in the US.

Patients with gastrointestinal diseases are at an elevated risk of nutritional deterioration as they are asked to fast before undergoing diagnostic tests. They may also face nutritional deterioration due to therapeutic dietary restriction and loss of appetite caused by anorexia or altered nutritional requirements, which can be a result of the disease itself. Thus, medical nutrition is recommended for these patients due to their inability to ingest food. Enteral routes are preferred to provide them with essential nutrients. Enteral feeding refers to the direct intake of food nutrients through the mouth or through a tube that passes the digestive tract (mouth to stomach/small intestine and then anus). This type of nutrition is preferred to provide treatment support for patients suffering from chronic ailments, such as neurological disorders, gastrointestinal diseases, and inherited metabolic diseases. Therefore, the surging prevalence of gastrointestinal diseases drives the growth of the enteral nutrition market.

North America Enteral Nutrition Market Overview

The North America enteral nutrition market is segmented into the US, Canada, and Mexico. North America accounts for a significant market share owing to the rising prevalence of chronic diseases, growing strategic developments by market players, and increasing preference for enteral nutrition contribute to the market progress in this region. Moreover, an upsurge in knowledge among individuals about the benefits of medical nutrition, such as tube feeding, in the treatment of chronic health conditions are anticipated to boost the North America enteral nutrition market growth during the forecast period.

Chronic diseases, such as cancer and heart disease, are the major causes of disability and death in the US. Per the National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 people in the country have at least one chronic disease. Additionally, the American Hospital Association estimates ~133 million people have at least one chronic disease, and that number is expected to reach 170 million by 2030. Enteral tube feeding can be prescribed for treating more than 350 disease conditions in children.

North America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)

North America Enteral Nutrition Market Segmentation

The North America enteral nutrition market is segmented based on product type, application, age group, distribution channel, and country.

Based on product type, the North America enteral nutrition market is bifurcated into general and disease specific. The general segment held a larger North America enteral nutrition market share in 2022.

In terms of application, the North America enteral nutrition market is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held the largest North America enteral nutrition market share in 2022.

Based on age group, the North America enteral nutrition market is bifurcated into adult and pediatric. The adult segment held a larger North America enteral nutrition market share in 2022.

By distribution channel, the North America enteral nutrition market is segmented into hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest North America enteral nutrition market share in 2022.

Based on country, the North America enteral nutrition market is categorized into the US, Canada, and Mexico. The US dominated the North America enteral nutrition market in 2022.

Abbott Laboratories, Nestle SA, Danone SA, Fresenius SE & Co KGaA, B Braun SE, Dr Schar AG, Reckitt Benckiser Group Plc, Nutritional Medicinals LLC, Kate Farms Inc, Royal FrieslandCampina NV, Arla Foods amba, Perrigo Co Plc, and Fonterra Co-Operative Group Ltd are some of the leading companies operating in the North America enteral nutrition market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Enteral Nutrition Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Increasing Prevalence of Gastrointestinal Diseases
    • 4.1.2 Rising Cases of Malnutrition and Premature Births
  • 4.2 Market Restraints
    • 4.2.1 Complications Associated with Enteral Feeding Systems
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives by Key Market Players
  • 4.4 Future Trends
    • 4.4.1 Specific Formulations and Plant-Based Nutrition Products
  • 4.5 Impact Analysis

5. Enteral Nutrition Market - North America Market Analysis

  • 5.1 North America Enteral Nutrition Market Revenue (US$ million), 2022 - 2030

6. North America Enteral Nutrition Market - Revenue and Forecast to 2030 - by Product Type

  • 6.1 Overview
  • 6.2 North America Enteral Nutrition Market Revenue Share, by Product Type 2022 & 2030 (%)
  • 6.3 General
    • 6.3.1 Overview
    • 6.3.2 General: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 North America Enteral Nutrition Market, by General
        • 6.3.2.1.1 North America Enteral Nutrition Market, by Elemental Formula
  • 6.4 Disease Specific
    • 6.4.1 Overview
    • 6.4.2 Disease Specific: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Enteral Nutrition Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 North America Enteral Nutrition Market Revenue Share, by Application 2022 & 2030 (%)
  • 7.3 Gastrointestinal Disorder
    • 7.3.1 Overview
    • 7.3.2 Gastrointestinal Disorder: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Metabolic/Inborn Errors of Metabolism
    • 7.4.1 Overview
    • 7.4.2 Metabolic/Inborn Errors of Metabolism: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Allergy
    • 7.5.1 Overview
    • 7.5.2 Allergy: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Renal Disease
    • 7.6.1 Overview
    • 7.6.2 Renal Disease: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Liver Disease
    • 7.7.1 Overview
    • 7.7.2 Liver Disease: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Oncology
    • 7.8.1 Overview
    • 7.8.2 Oncology: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Neurology
    • 7.9.1 Overview
    • 7.9.2 Neurology: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Enteral Nutrition Market - Revenue and Forecast to 2030 - by Age Group

  • 8.1 Overview
  • 8.2 North America Enteral Nutrition Market Revenue Share, by Age Group 2022 & 2030 (%)
  • 8.3 Adult
    • 8.3.1 Overview
    • 8.3.2 Adult: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Pediatric
    • 8.4.1 Overview
    • 8.4.2 Pediatric: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Enteral Nutrition Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 North America Enteral Nutrition Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Hospital Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacies: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Retail Stores
    • 9.4.1 Overview
    • 9.4.2 Retail Stores: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 E-Commerce
    • 9.5.1 Overview
    • 9.5.2 E-Commerce: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Enteral Nutrition Market - Country Analysis

  • 10.1 North America Enteral Nutrition Market, Revenue and Forecast To 2030
    • 10.1.1 North America Enteral Nutrition Market, by Country
      • 10.1.1.1 US
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
        • 10.1.1.1.3 US Enteral Nutrition Market, by Product Type
        • 10.1.1.1.3.1 US Enteral Nutrition Market, by General
        • 10.1.1.1.3.1.1 US Enteral Nutrition Market, by Elemental Formula
        • 10.1.1.1.4 US Enteral Nutrition Market, by Application
        • 10.1.1.1.5 US Enteral Nutrition Market, by Age Group
        • 10.1.1.1.6 US Enteral Nutrition Market, by Distribution Channel
      • 10.1.1.2 Canada
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
        • 10.1.1.2.3 Canada Enteral Nutrition Market, by Product Type
        • 10.1.1.2.3.1 Canada Enteral Nutrition Market, by General
        • 10.1.1.2.3.1.1 Canada Enteral Nutrition Market, by Elemental Formula
        • 10.1.1.2.4 Canada Enteral Nutrition Market, by Application
        • 10.1.1.2.5 Canada Enteral Nutrition Market, by Age Group
        • 10.1.1.2.6 Canada Enteral Nutrition Market, by Distribution Channel
      • 10.1.1.3 Mexico
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
        • 10.1.1.3.3 Mexico Enteral Nutrition Market, by Product Type
        • 10.1.1.3.3.1 Mexico Enteral Nutrition Market, by General
        • 10.1.1.3.3.1.1 Mexico Enteral Nutrition Market, by Elemental Formula
        • 10.1.1.3.4 Mexico Enteral Nutrition Market, by Application
        • 10.1.1.3.5 Mexico Enteral Nutrition Market, by Age Group
        • 10.1.1.3.6 Mexico Enteral Nutrition Market, by Distribution Channel

11. Enteral Nutrition Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Enteral Nutrition Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Nestle SA
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Danone SA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Fresenius SE & Co KGaA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 B Braun SE
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Dr Schar AG
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Reckitt Benckiser Group Plc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Nutritional Medicinals LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Kate Farms Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Royal FrieslandCampina NV
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Arla Foods amba
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Perrigo Co Plc
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 Fonterra Co-Operative Group Ltd
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America Enteral Nutrition Market Segmentation
  • Table 2. North America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - General
  • Table 3. North America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 4. US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Product Type
  • Table 5. US Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - General
  • Table 6. US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 7. US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Application
  • Table 8. US Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Age Group
  • Table 9. US Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Distribution Channel
  • Table 10. Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Product Type
  • Table 11. Canada Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - General
  • Table 12. Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 13. Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Application
  • Table 14. Canada Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Age Group
  • Table 15. Canada Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Distribution Channel
  • Table 16. Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Product Type
  • Table 17. Mexico Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - General
  • Table 18. Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 19. Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Application
  • Table 20. Mexico Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Age Group
  • Table 21. Mexico Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Distribution Channel
  • Table 22. Recent Inorganic Growth Strategies in the Enteral Nutrition Market
  • Table 23. Recent Organic Growth Strategies in the Enteral Nutrition Market
  • Table 24. Glossary of Terms, Enteral Nutrition Market

List Of Figures

  • Figure 1. North America Enteral Nutrition Market Segmentation, By Country
  • Figure 2. North America Enteral Nutrition Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Enteral Nutrition Market Revenue (US$ million), 2020 - 2030
  • Figure 5. North America Enteral Nutrition Market Revenue Share, by Product Type 2022 & 2030 (%)
  • Figure 6. General: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Disease Specific: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. North America Enteral Nutrition Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 9. Gastrointestinal Disorder: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Metabolic/Inborn Errors of Metabolism: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Allergy: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Renal Disease: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Liver Disease: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Oncology: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Neurology: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Others: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. North America Enteral Nutrition Market Revenue Share, by Age Group 2022 & 2030 (%)
  • Figure 18. Adult: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Pediatric: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Enteral Nutrition Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 21. Hospital Pharmacies: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Retail Stores: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. E-Commerce: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. North America Enteral Nutrition Market, 2022 (US$ million)
  • Figure 26. North America Enteral Nutrition Market, By Key Countries, 2022 and 2030 (%)
  • Figure 27. US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
  • Figure 28. Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
  • Figure 29. Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
  • Figure 30. Growth Strategies in the Enteral Nutrition Market